Erschienen in:

01.03.2009 | ORIGINAL COMMUNICATION

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

verfasst von: M. Hutchinson, MD, L. Kappos, P. A. Calabresi, C. Confavreux, G. Giovannoni, S. L. Galetta, E. Havrdova, F. D. Lublin, D. H. Miller, P. W. O’Connor, J. T. Phillips, C. H. Polman, E.-W. Radue, R. A. Rudick, W. H. Stuart, A. Wajgt, B. Weinstock-Guttman, D. R. Wynn, F. Lynn, M. A. Panzara, for the AFFIRM and SENTINEL Investigators

Erschienen in: Journal of Neurology | Ausgabe 3/2009